We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDNW
3601
RideNow Group
RDNW
$247M
$21.4K ﹤0.01%
+2,635
New +$16.9K
NTCO
3602
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$21.4K ﹤0.01%
3,133
+1,520
+94% +$9.14K
THRD
3603
DELISTED
Third Harmonic Bio
THRD
$21.4K ﹤0.01%
1,953
-187
-9% -$1.48K
VVOS icon
3604
Vivos Therapeutics
VVOS
$4.11M
$21.4K ﹤0.01%
+1,718
New +$14.7K
GTLB icon
3605
GitLab
GTLB
$7.21B
$21.3K ﹤0.01%
339
+19
+6% +$960
NB
3606
NioCorp Developments
NB
$754M
$21.3K ﹤0.01%
6,686
-11,758
-64% -$42.5K
DFTX
3607
Definium Therapeutics
DFTX
$5.78B
$21.3K ﹤0.01%
5,820
+5,687
+4,276% +$17.1K
VNET
3608
VNET Group
VNET
$2.17B
$21.3K ﹤0.01%
7,407
-3,281
-31% -$9.87K
IMCR icon
3609
Immunocore
IMCR
$1.72B
$21.2K ﹤0.01%
311
-3,077
-91% -$160K
PLX icon
3610
Protalix BioTherapeutics
PLX
$183M
$21.2K ﹤0.01%
11,932
+5,179
+77% +$8.05K
CXDO icon
3611
Crexendo
CXDO
$218M
$21.2K ﹤0.01%
4,375
-921
-17% -$2.42K
BLND icon
3612
Blend Labs
BLND
$362M
$21.2K ﹤0.01%
8,309
+6,188
+292% +$9.33K
SHIP icon
3613
Seanergy Maritime Holdings
SHIP
$360M
$21.1K ﹤0.01%
+2,697
New +$16.8K
AP icon
3614
Ampco-Pittsburgh
AP
$197M
$21.1K ﹤0.01%
7,729
+3,212
+71% +$8.61K
FDBC icon
3615
Fidelity D&D Bancorp
FDBC
$322M
$21K ﹤0.01%
362
+45
+14% +$2.28K
EUM icon
3616
ProShares Trust Short MSCI Emerging Markets
EUM
$9.28M
$21K ﹤0.01%
742
-117
-14% -$3.54K
FDUS icon
3617
Fidus Investment
FDUS
$746M
$20.9K ﹤0.01%
1,062
-2,014
-65% -$38.4K
JBIO
3618
Jade Biosciences
JBIO
$1.55B
$20.9K ﹤0.01%
26
-15
-37% -$7.64K
VALU icon
3619
Value Line
VALU
$347M
$20.8K ﹤0.01%
426
-625
-59% -$26.6K
BPRN icon
3620
Princeton Bancorp
BPRN
$297M
$20.8K ﹤0.01%
578
-65
-10% -$2.11K
MAYS icon
3621
J.W. Mays
MAYS
$20.7K ﹤0.01%
494
-1,074
-68% -$48.1K
ACTG icon
3622
Acacia Research
ACTG
$445M
$20.7K ﹤0.01%
5,291
-18,546
-78% -$68.6K
SCHG icon
3623
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$20.7K ﹤0.01%
1,000
-4,884
-83% -$94.5K
TSBK icon
3624
Timberland Bancorp
TSBK
$358M
$20.7K ﹤0.01%
659
-640
-49% -$18.7K
BAM icon
3625
Brookfield Asset Management
BAM
$86.8B
$20.7K ﹤0.01%
516
-1,918
-79% -$64.8K
143 144
145
146 147

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.